Citius Oncology, Inc.
CTOR · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $311,253 | $66,544 | $82,285 | $99,458 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $3,800 | $3,800 | $3,800 | $3,800 |
| Enterprise Value | $315,053 | $70,344 | $86,085 | $103,258 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$4,945 | -$7,471 | -$6,395 | -$6,669 |
| % Margin | – | – | – | – |
| Net Income | -$5,370 | -$7,736 | -$6,659 | -$6,813 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.075 | -0.11 | -0.093 | -0.098 |
| % Growth | 31.8% | -18.2% | 4.7% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |